Aberdeen Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-255,147
| Closed | -$26.4M | – | 964 |
|
|
2020
Q3 | $26.4M | Sell |
255,147
-152,942
| -37% | -$15.8M | 0.07% | 228 |
|
|
2020
Q2 | $32.3M | Sell |
408,089
-109,953
| -21% | -$8.7M | 0.09% | 205 |
|
|
2020
Q1 | $30M | Sell |
518,042
-20,875
| -4% | -$1.21M | 0.1% | 176 |
|
|
2019
Q4 | $29.1M | Buy |
538,917
+34,074
| +7% | +$1.84M | 0.07% | 250 |
|
|
2019
Q3 | $26.4M | Sell |
504,843
-205,408
| -29% | -$10.7M | 0.07% | 265 |
|
|
2019
Q2 | $34.3M | Buy |
710,251
+170,268
| +32% | +$8.23M | 0.08% | 249 |
|
|
2019
Q1 | $27.3M | Sell |
539,983
-247,043
| -31% | -$12.5M | 0.06% | 296 |
|
|
2018
Q4 | $46.1M | Sell |
787,026
-310,421
| -28% | -$18.2M | 0.11% | 159 |
|
|
2018
Q3 | $72.2M | Sell |
1,097,447
-337,882
| -24% | -$22.2M | 0.13% | 146 |
|
|
2018
Q2 | $72.5M | Sell |
1,435,329
-68,969
| -5% | -$3.48M | 0.14% | 143 |
|
|
2018
Q1 | $79.2M | Sell |
1,504,298
-259,199
| -15% | -$13.6M | 0.16% | 136 |
|
|
2017
Q4 | $82M | Buy |
1,763,497
+66,909
| +4% | +$3.11M | 0.16% | 127 |
|
|
2017
Q3 | $68.6M | Buy |
+1,696,588
| New | +$68.6M | 0.13% | 155 |
|